David C. Paul, born in 1959, is the founder of Globus Medical and served as its CEO from 2003 until mid-2017. During his time at the helm, he transitioned the company into a key player in the medical device industry,...

David C. Paul, born in 1959, is the founder of Globus Medical and served as its CEO from 2003 until mid-2017. During his time at the helm, he transitioned the company into a key player in the medical device industry, focusing on innovative spinal surgery technologies. He holds about 225 patents, highlighting his commitment to product development and innovation. After stepping down as CEO, he became the Executive Chairman, continuing his involvement in the company while mentoring the new leadership. His background includes significant roles at Synthes, where he managed product development. Through substantial insider trading activities, his wealth has varied greatly, peaking at $1.82 billion in September 2021. Under his leadership, Globus Medical hit impressive revenue targets, including a target of $690 million for 2018. David’s experience and strategic decisions helped shape Globus into a modern medical powerhouse.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other Globus Medical CEOs

G

David C. Paul

Founder and Ex-CEO of Globus Medical

Education

N/A

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

January 1, 1959 - 66 years ago

CEO of Globus Medical for

14 years 7 months (Jan 2003 - Aug 2017)

Previous Experience

Chairman and CEO of Globus Medical, Inc. since its inception in 2003.

Rivals

Competitors/colleagues of David C. Paul

Holdings

See how much did David C. Paul make over time.

David C. Paul has seen significant fluctuations in his wealth over time tied to Globus Medical’s stock performance. His holdings peaked at around $1.82 billion in September 2021 and experienced notable dips and recoveries throughout the years. For instance, in...

David C. Paul has seen significant fluctuations in his wealth over time tied to Globus Medical’s stock performance. His holdings peaked at around $1.82 billion in September 2021 and experienced notable dips and recoveries throughout the years. For instance, in early 2020, his wealth was approximately $921 million, reflecting volatility in the stock market. By January 2021, his holdings increased to $1.45 billion, continuing to rise before hitting the peak. Most recently, his wealth is around $1.57 billion as of September 2024, showcasing his substantial stake in Globus Medical despite the ups and downs in value.

Total Stock Sold

$243.46M

GMED

$243.46M

7,848,560 GMED shares

What if they kept their stock?

If David C. Paul didn't sell their stock, today they would have:
Extra GMED7,848,560 shares worth $379.24M.
This is 55.77% and $135.78M more than what they got when they sold the stock.

Charitable Transactions

GMED

1,000,000 shares

GMED

Recent Charitable Transactions

GMED

500,000 shares

GMED

Jan 20, 2015

Charity

GMED

500,000 shares

GMED

Jan 20, 2015

Charity

Insider Trading

See recent insider trades of David C. Paul.

GMED

$111.19M

GMED at $54.15/share

Sep 24, 2018

Sale

GMED

$362.23K

GMED at $52.95/share

Jul 17, 2018

Sale

GMED

$42.84M

GMED at $51.80/share

Apr 26, 2018

Sale

GMED

$48.05M

GMED at $25.00/share

Mar 18, 2015

Sale

GMED

500,000 shares

GMED

Jan 20, 2015

Charity

GMED

500,000 shares

GMED

Jan 20, 2015

Charity

GMED

$33.92M

GMED at $11.16/share

Aug 8, 2012

Sale

Compensation History

See how much did David C. Paul make over time.

David C. Paul's compensation as CEO has varied significantly over the years. In 2015, he earned $1,678,183, which included a salary of $430,000 and a notable bonus of $649,408 tied to performance metrics. By 2016, his total compensation dropped to $200,160, mainly due to no bonuses being awarded. However, in 2017, he made a considerable increase, with a total compensation of $2,246,643, including stock options exercised worth over $1.3 million. His pay structure emphasized performance-based compensation, making him a key player in driving the company's goals. Even after transitioning to Executive Chairman, he continued to play a significant role in compensation discussions.

Year

2017

Total Compensation

$411.71K

Salary

$380.16K

Board Justification

The compensation philosophy is centered on attracting and retaining talented leaders, with a focus on performance-based compensation that aligns with shareholder returns.

Bonus

$0.00

Board Justification

No bonus was paid in 2018.

Other

$31.55K

Board Justification

Includes participation in group health insurance benefits and other perquisites.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock was vested in 2018 as the focus is on cash compensation.

Performance Metrics

The performance metrics include achieving corporate objectives, particularly sales revenue, with a target revenue goal of $690 million for 2018.

Other Globus Medical CEOs

Here are other CEOs of Globus Medical

David M. Demski

Ex-CEO of Globus Medical

August 2017 - April 2022